Navigation Links
XRMD: Beyond AREDS2: Vision Improvement using Hormones, Genetics, Methylation, Nutrition and Anti-Oxidative Therapy
Date:5/16/2013

Cleveland Ohio (PRWEB) May 16, 2013

George Rozakis MD, author and pioneering Ophthalmologist who helped innovate the Lasik procedure claims that it is possible to improve visual acuity in patients with macular degeneration if the macula is "marginal". This is especially timely given the recent failure of AREDS2 anti-oxidation vitamin and supplement study to show significant benefit for the eye over AREDS1. He defines "marginal" as a macula whose critical cells are still alive but struggling to be healthy. These patients have lost vision, but there is still time to rejuvenate these cells before they die" using human genome science, methylation biochemistry, bioidentical hormones, anti-oxidation and genetically guided nutrition.

A representative patient writes: "… I couldn't read.... Letters were popping out darker and others were behind and I couldn't make them out to read. I actually would cry because I thought I would never be able to read again … My husband was sad when he saw I had hugely enlarged the lettering on my kindle to read. A few weeks or a month after I was on your program I had my kindle at small size lettering. I was so happy that I could read again. When we went to Barnes and Noble I had to leave because I couldn't read. Now we can go again. I can live with the way my eyes are now and be happy. I don't ever want to return to the way my eyes were. Please continue to study this so maybe someday it will prevent others from getting it at all."

Dr. Rozakis states, "this result is not a first. Our first patient years ago impressed me when she stated how her night vision improved within about a month of treatment. That was not expected and unsolicited. After the improvement in vision we generally see stability." Dr. Emhof, a board certified family practitioner adds, "the same therapy that benefits the macula also benefits overall health and wellness, thus offering the macular patient multiple benefits. We rarely see that with anti-oxidative therapy alone."

"The reason these patients improve is because we are optimizing the health of the eye at the cellular level by unblocking methylation pathways, anti-oxidation and optimizing hormones along with nutritional support geared to the genetic makeup of the patient." Optometrist Scott Sedlacek agrees. "The key to this therapeutic approach for the retinal pigment epithelial cells that are sick in macular degeneration is that it is not limited to anti-oxidation as was done in AREDS1 and ARDES2. Results showing an improvement in vision is a paradigm shift and it tells us that this approach is worthy of intense study. Optometry and Ophthalmology must focus on the prevention and treatment of disease instead of helplessly watching a patient's vision deteriorate over time and providing incomplete therapies such as AREDS1 and AREDS2 that create a false sense of security by delivering only one modality of therapy."

Brian A. Bakke, a PhD in bio-organic chemistry and expert in unblocking methylation pathways concurs. "The impetus to only focus on anti-oxidation may have been a good idea in 2008 when the AREDS2 study began and we do employ anti-oxidative nutraceuticals, however in today's world of genetic bio-science there are more and better ways to optimize cellular health. We are finding that patients with macular degeneration have insufficient hormonal levels and problems in the methionine and transsulfuration pathway. This tells us that the retinal pigment epithelial cells, which become sick in macular degeneration, degenerate due to their inability to keep up with the tremendous demands placed on them within eye.

"In the early stage of macular degeneration, vision is still good and no improvement is possible", said Dr. Rozakis "Here the goal of therapy is stability. In late disease where the pigment epithelial cells and rods and cones are severely compromised or dead, no improvement is possible." The "marginal" macula with mild to moderate visual loss offers us an excellent opportunity to improve cellular function and measure a result."

"Do we have all the answers? Of course not, but the key is that we apply all the answers we have and not limit ourselves to anti-oxidative therapy as in AREDS2." said Dr. Rozakis. "Finding hormonal and genetic errors and being able to treat them is today's paradigm shift." As for rebuilding a severely degenerated macula, the hope is that stem cells can repopulate the pigment epithelium and that the rods and codes can reform as well. That is the future. In the meantime we must keep our existing pigment epithelial cells and rods and cones healthy using genetic knowledge, methylation science, hormones, anti-oxidation and nutrition all aimed at the cellular level." For more information contact Dr Rozakis at 440-777-2667 or visit xrmd.com.

xRMD specializes in the turbocharging of current wellness programs by the delivery of advanced medical information to the doctor - patient relationship to optimize cellular function using genetics, methylation biochemistry, bioidentical hormones, and nutrition. xRMD clinical science coupled with traditional wellness can prevent and treat disease, improve the quality of life of patients, lower the cost of health care, and improve productivity in the workplace.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10716838.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Skin Safety Goes Beyond Sun Rays and SPF This Summer with New Ways to Protect Your Health
2. Beyond Rules—Sean A. Anderson’s Remarkable 275 Pound Weight-Loss Approach Now on Paperback and E-book
3. Beyond OCD Advisor Gail B. Adams to Speak in Sweden
4. Arizona Assisted Living Placement Service Above and Beyond Is Offering New Promotion for Clients
5. Post Pregnancy Weight Loss
6. How “Beyond Baby” Helps Women Lose Weight After Pregnancy – Vkool.com
7. Kimberly Williams-Paisley to Headline "An Evening That Will Live Beyond" Fundraiser on April 18th
8. Nationally Renowned Health Expert Debuts Book "Sex and Spaghetti Sauce: My Italian Mother’s Recipe for Getting Healthy and Getting Busy in Your 50s and Beyond"
9. Popular Natural Remedy Goes Beyond Skin Deep; Zion Health's Clay Bath Detox Minerals are Now Available at Lassens Natural Foods and Vitamins Stores in Southern California
10. Brad Paisley Partners with LiveBeyond for the "Beat This Summer Tour Presented by Cracker Barrel"
11. Mona H. Berman Kicks Off 2013 Beyond OCD Live Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... , ... May 28, 2016 , ... SuperCloset is proud ... too well the day to day issues, struggles and obstacles veterans’ need to overcome ... Veterans Grow Project provides active or retired military veteran(s) with a donated SuperCloset product ...
(Date:5/28/2016)... ... May 28, 2016 , ... In a part of the city where’s it’s easy to spot ... Kelowna restaurants is hoping to attract diners with a taste for real food. ... opened the doors to Cornerstone Grill, an urban casual restaurant focusing on dishes made by ...
(Date:5/27/2016)... New Hampshire (PRWEB) , ... May 27, 2016 , ... ... skin care products, announced today that it has been recognized as one of the ... entering parenthood. Badger was named as one of nine small businesses providing progressive benefits ...
(Date:5/27/2016)... ... May 27, 2016 , ... An educational campaign aimed at ... stories, courtesy of awareness-driven celebrities and thought leaders. It also provides insight to ... industry leaders such as Bioness. , As patients feel increasingly concerned about ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Aimed at ... human interest stories, which come courtesy of leaders in the nursing and health care ... from leading advocates and associations—namely Abilene Christian University. , As the nursing industry ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... HILDEN , Deutschland und GERMANTOWN, ... Zusammenarbeit mit Therawis bedient ... Entscheidungen bei Brustkrebs   QIAGEN N.V. ... QIA) gab heute bekannt, eine Lizenz- und Entwicklungsvereinbarung ... prädiktiver Assays für die Onkologie eingegangen zu sein. ...
(Date:5/25/2016)... As illustrated by the Spring ... the numbers and momentum of cannabis in the US ... billions, more research and development push the sector forward. ... Legal Marijuana Markets Report  from from ArcView Market Research ... the increase in sector is attributed to adult use ...
(Date:5/25/2016)... 25, 2016 ReportsnReports.com adds ... report that provides an overview on therapeutic pipeline ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Chronic ...
Breaking Medicine Technology: